Overexpression of sialomucin complex, a rat homologue of MUC4, inhibits tumor killing by lymphokine-activated killer cells

Cancer Research

Volumn 59, Issue 9, 1999, Pages 2229-2236

  Komatsu, Masanobu ^a   Yee, Lisa ^b   Carraway, Kermit L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SIALOMUCIN;

ARTICLE; BREAST CANCER; HUMAN; HUMAN CELL; LYMPHOKINE ACTIVATED KILLER CELL; MELANOMA CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

ANIMALS; ANTIGENS, NEOPLASM; ASCITES; BREAST NEOPLASMS; CYTOTOXICITY, IMMUNOLOGIC; DIMERIZATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOLOGIC SURVEILLANCE; INTERCELLULAR ADHESION MOLECULE-1; KILLER CELLS, LYMPHOKINE-ACTIVATED; MELANOMA; MICROSPHERES; MUCINS; NEOPLASM METASTASIS; PLEURAL EFFUSION, MALIGNANT; RATS; SIALOGLYCOPROTEINS; TRANSFECTION;

EID: 0033135026     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Naftzger, C., and Houghton, A. N. Tumor immunology. Curr. Opin. Oncol., 3:93-99, 1991.
2. Torre Amione, G., Beauchamp, R. D., Koeppen, H., Park, B. H., Schreiber, H., Moses, H. L., and Rowley, D. A. A highly immunogenic tumor transfected with a murine transforming growth factor type 9β1 cDNA escapes immune surveillance. Proc. Natl. Acad. Sci. USA, 87: 1486-1490, 1990.
3. Tada, T., Ohzeki, S., Utsumi, K., Takiuchi, H., Muramatsu, M., Li, X. F., Shimizu, J., Fujiwara, H., and Hamaoka, T. Transforming growth factor-β-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state. J. Immunol., 146: 1077-1082, 1991.
4. Bodmer, W. F., Browning, M. J., Krausa, P., Rowan, A., Bicknell, D. C., and Bodmer, J. G. Tumor escape from immune response by variation in HLA expression and other mechanisms. Ann. N. Y. Acad. Sci., 690: 42-49, 1993.
5. Becker, J. C., and Brocker, E. B. Lymphocyte-melanoma interaction: role of surface molecules. Rec. Results Cancer Res., 139: 205-214, 1995.
6. van de Wiel-van Kemenade, E., Ligtenberg, M. J., de Boer, A. J., Buijs, F., Vos, H. L., Melief, C. J., Hilkens, J., and Figdor, C. G. Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction. J. Immunol., 151: 767-776, 1993.
7. Sheng Z. Q., Hull, S. R., and Carraway, K. L. Biosynthesis of the cell surface sialomucin complex of ascites 13762 rat mammary adenocarcinoma cells from a high molecular weight precursor. J. Biol. Chem., 265: 8505-8510, 1990.
8. Wu, K., Fregien, N., and Carraway, K. L. Molecular cloning and sequencing of the mucin subunit of a heterodimeric, bifunctional cell surface glycoprotein complex of ascites rat mammary adenocarcinoma cells. J. Biol. Chem., 269: 11950-11955, 1994.
9. Komatsu, M., Carraway, C. A. C., Fregien, N. L., and Carraway, K. L. Reversible disruption of cell-matrix and cell-cell interactions by overexpression of sialomucin complex. J. Biol. Chem., 272: 33245-33254, 1997.
10. Spielman, J., Rockley, N. L., and Carraway, K. L. Temporal aspects of O-glycosylation and cell surface expression of ascites sialoglycoprotein-1, the major cell surface sialomucin of 13762 mammary ascites tumor cells. J. Biol. Chem., 262: 269-275, 1987.
11. Moriarty, J., Skelly, C. M., Bharathan, S., Moody, C. E., and Sherblom, A. P. Sialomucin and lytic susceptibility of rat mammary tumor ascites cells. Cancer Res., 50: 6800-6805, 1990.
12. Nollet, S., Moniaux, N., Maury, J., Petitprez, D., Degand, P., Laine, A., Porchet, N., and Aubert, J. P. Human mucin gene MUC4: organization of its 5′-region and polymorphism of its central tandem repeat array. Biochem. J., 332: 739-748, 1998.
13. Wu, K., Salas, P. J., Yee, L., Fregien, N., and Carraway, K. L. Tissue and tumor expression of a cell surface glycoprotein complex containing an integral membrane glycoprotein activator of p185neu. Oncogene, 9: 3139-3147, 1994.
14. Sherblom, A. P., Buck, R. L., and Carraway, K. L. Purification of the major sialoglycoproteins of 13762 MAT-B1 and MAT-C1 rat ascites mammary adenocarcinoma cells by density gradient centrifugation in cesium chloride and guanidine hydrochloride. J. Biol. Chem., 255: 783-790, 1980.
15. Hynes, N. E., and Stern, D. F. The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim. Biophys. Acta, 1198: 165-184, 1994.
16. Seregni, E., Botti, C., Massaron, S., Lombardo, C., Capobianco, A., Bogni, A., and Bombardieri, E. Structure, function and gene expression of epithelial mucins. Tumori, 83: 625-632, 1997.
17. Huggins, J. W., Trenbeath, T. P., Sherblom, A. P., Howard, S. C., and Carraway K. L. Glycoprotein differences in solid and ascites forms of the 13762 rat mammary adenocarcinoma. Cancer Res., 40: 1873-1878, 1980.
18. Codington, J. F., and Frim, D. M. Cell-surface macromolecular and morphological changes related to allotransplantability in the TA3 tumor. Biomembranes, 11: 207-258, 1983.
19. Becker, J. W., Erickson, H. P., Hoffman, S., Cunningham, B. A., and Edelman, G. M. Topology of cell adhesion molecules. Proc. Natl. Acad. Sci. USA, 86: 1088-1092, 1989.
20. Bjorkman, P. J. Structure, function, and diversity of class 1 major histocompatibility complex molecules. Annu. Rev. Biochem., 59: 253-288, 1990.
21. Jentoft, N. Why are proteins O-glycosylated? Trends Biochem. Sci., 15: 291-294, 1990.
22. Tsuboi, S., and Fukuda, M. Branched O-linked oligosaccharides ectopically expressed in transgenic mice reduce primary T-cell immune responses. EMBO J., 16: 6364-6373, 1997.
23. Takahashi, T., Makiguchi, Y., Hinoda, Y., Kakiuchi, H., Nakagawa, N., Imai, K., and Yachi, A. Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient. J. Immunol., 153: 2102-2109, 1994.
24. Magarian-Blander, J., Ciborowski, P., Hsia, S., Watkins, S. C., and Finn, O. J. Intercellular and intracellular events following the MHC-unrestricted TCR recognition of a tumor-specific peptide epitope on the epithelial antigen MUC1. J. Immunol., 160: 3111-3120, 1998.
25. Apostolopoulos, W., and McKenzie, F. C. Cellular mucins: targets for immunotherapy. Crit. Rev. Immunol., 14: 293-309, 1994.
26. North, S. M., Steck, P. A., Spohn, W. H., and Nicolson, G. L. Development and characterization of a syngeneic monoclonal antibody to a rat mammary tumor metastasis-associated mucin-like cell-surface antigen (gp580). Int. J. Cancer, 42: 607-614, 1988.
27. Storkus, W. J., Howell, D. N., Salter, R. D., Dawson, J. R., and Cresswell, P. NK susceptibility varies inversely with target cell class 1 HLA antigen expression. J. Immunol., 138: 1657-1659, 1987.
28. Lopez-Botet, M., Moretta, L., and Strominger, J. NK-cell receptors and recognition of MHC class I molecules. Immunol. Today, 17: 212-214, 1996.
29. Moretta, A., Sivori, S., Vitale, M., Pende, D., Morelli, L., Augugliaro, R., Bottino, C., and Moretta, L. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J. Exp. Med., 182: 875-884, 1995.
30. Moretta, L., Mingari, M. C., Pende, D., Bottino, C., Biassoni, R., and Moretta, A. The molecular basis of natural killer (NK) cell recognition and function. J. Clin. Immunol., 16: 243-253, 1996.
31. 125I-5-iodo-2′-deo-xyuridine. J. Natl. Cancer Inst. (Bethesda), 45: 737-782, 1970.
32. Riccardi, C., Puccetti, P., Santoni, A., and Herverman, R. Rapid in vivo assay of mouse natural killer (NK) cells activity. J. Natl. Cancer Inst. (Bethesda), 63: 1041-1045, 1979.
33. Komatsu, M. Multifunctional activities and contribution to metastasis of sialomucin complex (Ph.D. thesis). Miami: University of Miami, 1998.